Vident Advisory LLC Sells 602 Shares of Chemed Corporation $CHE

Key Points

• Vident Advisory LLC has reduced its position in Chemed Corporation (NYSE: CHE) by 44.9% in the first quarter, now holding 738 shares worth approximately $454,000.
• Chemed's stock has had a volatile performance, with a market capitalization of $6.79 billion and a current price around $465.72, significantly down from its fifty-two week high of $623.60.
• The company recently announced an increase in its quarterly dividend, now at $0.60 per share, up from $0.50, reflecting continued financial stability despite challenges.

Vident Advisory LLC cut its stake in shares of Chemed Corporation (NYSE:CHE - Free Report) by 44.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 738 shares of the company's stock after selling 602 shares during the period. Vident Advisory LLC's holdings in Chemed were worth $454,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Whipplewood Advisors LLC lifted its position in Chemed by 54.5% during the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock worth $31,000 after acquiring an additional 18 shares during the last quarter. Renasant Bank lifted its position in Chemed by 2.3% during the first quarter. Renasant Bank now owns 815 shares of the company's stock worth $501,000 after acquiring an additional 18 shares during the last quarter. Impact Capital Partners LLC lifted its position in Chemed by 2.7% during the first quarter. Impact Capital Partners LLC now owns 763 shares of the company's stock worth $469,000 after acquiring an additional 20 shares during the last quarter. KFG Wealth Management LLC lifted its position in Chemed by 4.6% during the first quarter. KFG Wealth Management LLC now owns 525 shares of the company's stock worth $323,000 after acquiring an additional 23 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its position in Chemed by 16.1% during the first quarter. First Horizon Advisors Inc. now owns 173 shares of the company's stock worth $107,000 after acquiring an additional 24 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CHE has been the subject of several research reports. Jefferies Financial Group upgraded shares of Chemed from a "hold" rating to a "buy" rating and raised their price objective for the stock from $490.00 to $550.00 in a research report on Tuesday, September 2nd. Royal Bank Of Canada dropped their price target on shares of Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a research report on Thursday, July 31st. Wall Street Zen downgraded shares of Chemed from a "buy" rating to a "hold" rating in a research report on Saturday, July 5th. Bank of America dropped their price target on shares of Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a research report on Wednesday. Finally, Oppenheimer dropped their price target on shares of Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a research report on Thursday, July 31st. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $578.50.

Insider Buying and Selling at Chemed

In other Chemed news, EVP Nicholas Michael Westfall sold 10,012 shares of the business's stock in a transaction that occurred on Monday, August 4th. The shares were sold at an average price of $421.91, for a total transaction of $4,224,162.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director George J. Walsh III acquired 200 shares of the stock in a transaction on Monday, August 4th. The shares were purchased at an average price of $417.10 per share, with a total value of $83,420.00. Following the completion of the transaction, the director owned 3,523 shares of the company's stock, valued at approximately $1,469,443.30. This represents a 6.02% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 3.29% of the company's stock.

Chemed Price Performance

CHE traded down $11.89 during trading on Friday, hitting $446.00. 160,245 shares of the stock traded hands, compared to its average volume of 167,896. Chemed Corporation has a twelve month low of $408.42 and a twelve month high of $623.60. The company has a market cap of $6.50 billion, a price-to-earnings ratio of 22.93, a PEG ratio of 2.66 and a beta of 0.46. The business has a 50 day moving average price of $451.83 and a 200 day moving average price of $531.04.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing the consensus estimate of $6.02 by ($1.75). Chemed had a net margin of 11.56% and a return on equity of 25.83%. The firm had revenue of $618.80 million for the quarter, compared to analyst estimates of $650.60 million. During the same quarter in the prior year, the firm earned $5.47 earnings per share. The firm's revenue for the quarter was up 3.8% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, equities research analysts predict that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 11th were given a dividend of $0.60 per share. This is an increase from Chemed's previous quarterly dividend of $0.50. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date was Monday, August 11th. Chemed's dividend payout ratio (DPR) is presently 12.34%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.